The story appears on

Page A10

July 3, 2020

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Business

Boehringer opens China tech center

German pharmaceutical company Boehringer Ingelheim yesterday unveiled its External Innovation Hub in Shanghai.

In the next five years, the company will invest 451 million euros (US$507.9 million) in China in clinical research, production expansion and other research partnerships.

“Boehringer Ingelheim will continue to increase investment in China, including setting up the External Innovation Hub.

“The hub will become one of Boehringer Ingelheim’s strategic pillars,” said Felix Gutsche, president and CEO of Boehringer Ingelheim China.

The company expects to have 71 new products approved in China by 2030.

“COVID-19 has highlighted the importance of digital services.

“And our latest digital initiative hopes to integrate all the methodology and technology with real business needs,” he told Shanghai Daily.

“China is the first market to see business rebound after the coronavirus outbreak.”


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend